Heleen Dewitte
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- RNA Interference and Gene Delivery 18
- Immunology 19
- Immunotherapy and Immune Responses 18
- Co-authors
- Ine Lentacker (26 shared papers)Stefaan C. De Smedt (24 shared papers)Rein Verbeke (13 shared papers)Karine Breckpot (14 shared papers)Lucillia Bezu (1 shared paper)Radek Špíšek (1 shared paper)Oliver Kepp (1 shared paper)Lorenzo Galluzzi (1 shared paper)
- Journals
- Journal of Controlled Release (7 papers)Biomaterials (3 papers)Molecular Therapy — Nucleic Acids (2 papers)Nano Today (2 papers)Theranostics (2 papers)
- Partner nations
- BelgiumNetherlandsFrance
In The Last Decade
Heleen Dewitte
33 papers receiving 2.5k citations
Heleen Dewitte's Hit Papers
Peers
Comparison fields: 5 of 125
- Immunology 762
- Infectious Diseases 331
- Biomedical Engineering 799
- Biomaterials 232
- Molecular Biology 1.2k
Countries citing papers authored by Heleen Dewitte
This map shows the geographic impact of Heleen Dewitte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heleen Dewitte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heleen Dewitte more than expected).
Fields of papers citing papers by Heleen Dewitte
This network shows the impact of papers produced by Heleen Dewitte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heleen Dewitte. The network helps show where Heleen Dewitte may publish in the future.
Co-authors
The 25 scholars most cited alongside Heleen Dewitte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The dawn of mRNA vaccines: The COVID-19 case Hit paper breakdown → | 2021 | 351 |
| 2 | 2015 | 339 | |
| 3 | 2020 | 264 | |
| 4 | 2019 | 222 | |
| 5 | 2017 | 117 | |
| 6 | 2014 | 106 | |
| 7 | 2012 | 104 | |
| 8 | 2011 | 99 | |
| 9 | 2019 | 94 | |
| 10 | 2015 | 93 | |
| 11 | 2016 | 92 | |
| 12 | 2015 | 76 | |
| 13 | 2014 | 69 | |
| 14 | 2019 | 68 | |
| 15 | 2014 | 62 | |
| 16 | 2021 | 56 | |
| 17 | 2014 | 54 | |
| 18 | 2019 | 50 | |
| 19 | 2018 | 43 | |
| 20 | 2019 | 38 |
About Heleen Dewitte
Heleen Dewitte is a scholar working on Molecular Biology, Immunology, Biomedical Engineering, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 34 papers that have together received 2.6k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (18 papers), Immunotherapy and Immune Responses (18 papers), Ultrasound and Hyperthermia Applications (9 papers), Virus-based gene therapy research (6 papers), Photoacoustic and Ultrasonic Imaging (5 papers), Ultrasound and Cavitation Phenomena (5 papers), Ultrasound Imaging and Elastography (4 papers) and Nanoplatforms for cancer theranostics (4 papers). The work is most often cited by research in Immunology (762 citations), Infectious Diseases (331 citations), Biomedical Engineering (799 citations), Biomaterials (232 citations) and Molecular Biology (1.2k citations). Heleen Dewitte has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Ine Lentacker, Stefaan C. De Smedt, Rein Verbeke, Karine Breckpot, Lucillia Bezu, Radek Špíšek, Oliver Kepp, Lorenzo Galluzzi, Guido Kroemer and Jitka Fučíková. Their work appears in journals such as Journal of Controlled Release, Biomaterials, Molecular Therapy — Nucleic Acids, Nano Today and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.